FMI
F/M Investments Portfolio holdings
AUM
$2.75B
This Quarter Return
+12.59%
1 Year Return
+20.95%
3 Year Return
+124.61%
5 Year Return
–
10 Year Return
–
AUM
$2.75B
AUM Growth
+$2.75B
(+9.7%)
Cap. Flow
+$12.2M
Cap. Flow
% of AUM
0.44%
Top 10 Holdings %
Top 10 Hldgs %
34.07%
Holding
425
New
34
Increased
206
Reduced
124
Closed
25
Top Buys
| 1 |
TBIL
US Treasury 3 Month Bill ETF
TBIL
|
$12M |
| 2 |
RBIL
F/m Ultrashort Treasury Inflation-Protected Security (TIPS) ETF
RBIL
|
$9.91M |
| 3 |
Chipotle Mexican Grill
CMG
|
$9.21M |
| 4 |
O'Reilly Automotive
ORLY
|
$9.2M |
| 5 |
Intuitive Surgical
ISRG
|
$8.65M |
Top Sells
| 1 |
Coca-Cola
KO
|
$27.7M |
| 2 |
Thermo Fisher Scientific
TMO
|
$9.11M |
| 3 |
Exxon Mobil
XOM
|
$8.73M |
| 4 |
UnitedHealth
UNH
|
$6.32M |
| 5 |
Caterpillar
CAT
|
$6.05M |
Sector Composition
| 1 | Technology | 25.02% |
| 2 | Financials | 10.77% |
| 3 | Healthcare | 10.05% |
| 4 | Consumer Discretionary | 8.12% |
| 5 | Industrials | 7.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
OneSpan
OSPN
$572M
| $2.16M | 0.08% |
129,458
+307
| +0.2% | +$5.12K |
|
227
Merck
MRK
$214B
| $2.16M | 0.08% |
27,245
-1,522
| -5% | -$120K |
|
228
Phillips 66
PSX
$54.1B
| $2.16M | 0.08% |
18,066
+974
| +6% | +$116K |
|
229
Clorox
CLX
$14.7B
| $2.16M | 0.08% |
17,952
+769
| +4% | +$92.3K |
|
230
Ultragenyx Pharmaceutical
RARE
$3.09B
| $2.15M | 0.08% |
59,102
+788
| +1% | +$28.7K |
|
231
CVS Health
CVS
$94B
| $2.14M | 0.08% |
31,092
+1,752
| +6% | +$121K |
|
232
89bio
ETNB
$1.36B
| $2.14M | 0.08% |
217,742
+2,905
| +1% | +$28.5K |
|
233
Target
TGT
$42B
| $2.11M | 0.08% |
21,389
+1,256
| +6% | +$124K |
|
234
Astera Labs
ALAB
$29B
| $2.1M | 0.08% |
23,229
-488
| -2% | -$44.1K |
|
235
iShares Core S&P 500 ETF
IVV
$657B
| $2.09M | 0.08% |
3,645
+973
| +36% | +$557K |
|
236
Boston Scientific
BSX
$158B
| $2.09M | 0.08% |
19,422
-180
| -0.9% | -$19.3K |
|
237
SPS Commerce
SPSC
$4.04B
| $2.08M | 0.08% |
15,257
+12
| +0.1% | +$1.63K |
|
238
KalVista Pharmaceuticals
KALV
$719M
| $2.06M | 0.07% |
182,262
+132,165
| +264% | +$1.49M |
|
239
Guardant Health
GH
$8.29B
| $2.03M | 0.07% |
39,099
+471
| +1% | +$24.5K |
|
240
ADT
ADT
$7.04B
| $2.01M | 0.07% |
+237,425
| New | +$2.01M |
|
241
T Rowe Price
TROW
$23.2B
| $1.99M | 0.07% |
20,594
+1,189
| +6% | +$115K |
|
242
Berkshire Hathaway Class B
BRK.B
$1.08T
| $1.95M | 0.07% |
4,113
+713
| +21% | +$338K |
|
243
Manulife Financial
MFC
$51.8B
| $1.94M | 0.07% |
60,708
+4,554
| +8% | +$146K |
|
244
Goldman Sachs
GS
$221B
| $1.94M | 0.07% |
2,735
-1,533
| -36% | -$1.08M |
|
245
Alphatec Holdings
ATEC
$2.32B
| $1.93M | 0.07% |
173,945
+2,325
| +1% | +$25.8K |
|
246
Linde
LIN
$222B
| $1.89M | 0.07% |
+4,034
| New | +$1.89M |
|
247
McCormick & Company Non-Voting
MKC
$18.5B
| $1.89M | 0.07% |
24,962
-499
| -2% | -$37.8K |
|
248
FirstEnergy
FE
$25.1B
| $1.89M | 0.07% |
46,892
+2,690
| +6% | +$108K |
|
249
iShares MSCI Emerging Markets ETF
EEM
$18.9B
| $1.88M | 0.07% |
39,000
| – | – |
|
250
SPDR Portfolio S&P 600 Small Cap ETF
SPSM
$12.4B
| $1.86M | 0.07% |
43,671
| – | – |
|